These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 16453270

  • 1. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO, Keegan B, Long CA, Miller LH.
    J Infect Dis; 2006 Mar 01; 193(5):731-40. PubMed ID: 16453270
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC.
    Mol Med; 1995 Mar 15; 1(3):325-32. PubMed ID: 8529111
    [Abstract] [Full Text] [Related]

  • 4. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line.
    Baruch DI, Gamain B, Barnwell JW, Sullivan JS, Stowers A, Galland GG, Miller LH, Collins WE.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3860-5. PubMed ID: 11904437
    [Abstract] [Full Text] [Related]

  • 5. Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.
    Moll K, Pettersson F, Vogt AM, Jonsson C, Rasti N, Ahuja S, Spångberg M, Mercereau-Puijalon O, Arnot DE, Wahlgren M, Chen Q.
    Infect Immun; 2007 Jan 19; 75(1):211-9. PubMed ID: 17074852
    [Abstract] [Full Text] [Related]

  • 6. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR, Narum DL, Gozalo AS, Aguiar J, Fuhrmann SR, Liang H, Haynes JD, Moch JK, Lucas C, Luu T, Magill AJ, Hoffman SL, Sim BK.
    J Infect Dis; 2001 Jan 15; 183(2):303-312. PubMed ID: 11110648
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P, Ruebush TK, Campbell GH, Richman SJ, Wilkins PP, Broderson JR, Ardeshir F, Gross M, Silverman C, Skinner JC.
    Am J Trop Med Hyg; 1992 Jun 15; 46(6):691-707. PubMed ID: 1621894
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.
    Guillotte M, Juillerat A, Igonet S, Hessel A, Petres S, Crublet E, Le Scanf C, Lewit-Bentley A, Bentley GA, Vigan-Womas I, Mercereau-Puijalon O.
    PLoS One; 2015 Jun 15; 10(7):e0134292. PubMed ID: 26222304
    [Abstract] [Full Text] [Related]

  • 9. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
    Infect Immun; 2006 Aug 15; 74(8):4573-80. PubMed ID: 16861644
    [Abstract] [Full Text] [Related]

  • 10. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B, Hundt E, Knapp B.
    Mem Inst Oswaldo Cruz; 1992 Aug 15; 87 Suppl 3():413-22. PubMed ID: 1343721
    [Abstract] [Full Text] [Related]

  • 11. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF, Blackman MJ, Kaslow DC.
    Infect Immun; 2000 Mar 15; 68(3):1418-27. PubMed ID: 10678955
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.
    Dutta S, Sullivan JS, Grady KK, Haynes JD, Komisar J, Batchelor AH, Soisson L, Diggs CL, Heppner DG, Lanar DE, Collins WE, Barnwell JW.
    PLoS One; 2009 Dec 03; 4(12):e8138. PubMed ID: 19997632
    [Abstract] [Full Text] [Related]

  • 16. Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite.
    Jones TR, Obaldia N, Gramzinski RA, Hoffman SL.
    Am J Trop Med Hyg; 2000 Jun 03; 62(6):675-80. PubMed ID: 11304053
    [Abstract] [Full Text] [Related]

  • 17. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, Sedegah M, Wang R, Hobart P, Margalith M, Hoffman S.
    Vaccine; 1997 Jun 03; 15(8):913-5. PubMed ID: 9234546
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children.
    Dodoo D, Staalsoe T, Giha H, Kurtzhals JA, Akanmori BD, Koram K, Dunyo S, Nkrumah FK, Hviid L, Theander TG.
    Infect Immun; 2001 Jun 03; 69(6):3713-8. PubMed ID: 11349035
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
    Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA.
    Infect Immun; 2005 Jan 03; 73(1):287-97. PubMed ID: 15618165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.